Ask the Experts: Clinical Trial Design

All of the relevant financial relationships listed for these individuals have been mitigated. Unless otherwise noted, speakers have nothing to disclose.

Moderators

Joseph Sabik, III, MD
Disclosure(s): Mectronic: Advisory Board (Ongoing), Speaker (Ongoing)

Joanna Chikwe, MD

Presentations

  1. REvascularization CHoices Among Under-Represented Groups Evaluation (RECHARGE) Trial
    Mario FL Gaudino, MD, PhD, MSCE
    Disclosure(s): Abbott Vascular: Advisory Board (Terminated, May 12, 2023)
     
  2. Moderated Panel Discussion and Audience Q&A: RECHARGE Trial
    Mario FL Gaudino, MD, PhD, MSCE
    Disclosure(s): Abbott Vascular: Advisory Board (Terminated, May 12, 2023)

    Michael Farkouh, MD, MSc
    Disclosure(s): Astra Zeneca: Advisory Board (Ongoing); Novo Nordisk: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Sanofi: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated)

    Michael Mack, MD
    Disclosure(s): Carmat: Corporate Board Member (Ongoing); Edwards Lifesciences: Trial Co-PI (Ongoing); Medtronic: Study Chair (Ongoing)

    Sigrid E. Sandner, MD
Activity summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation
Activity opens: 
02/01/2024
Activity expires: 
02/15/2027
Cost:
$0.00
Rating: 
5

Available Credit

  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation

Price

Cost:
$0.00
Please login or register to take this course.

All of the relevant financial relationships listed for these individuals have been mitigated. Unless otherwise noted, speakers have nothing to disclose.

Moderators

Joseph Sabik, III, MD
Disclosure(s): Mectronic: Advisory Board (Ongoing), Speaker (Ongoing)

Joanna Chikwe, MD

Presentations

  1. REvascularization CHoices Among Under-Represented Groups Evaluation (RECHARGE) Trial
    Mario FL Gaudino, MD, PhD, MSCE
    Disclosure(s): Abbott Vascular: Advisory Board (Terminated, May 12, 2023)
     
  2. Moderated Panel Discussion and Audience Q&A: RECHARGE Trial
    Mario FL Gaudino, MD, PhD, MSCE
    Disclosure(s): Abbott Vascular: Advisory Board (Terminated, May 12, 2023)

    Michael Farkouh, MD, MSc
    Disclosure(s): Astra Zeneca: Advisory Board (Ongoing); Novo Nordisk: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Sanofi: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated)

    Michael Mack, MD
    Disclosure(s): Carmat: Corporate Board Member (Ongoing); Edwards Lifesciences: Trial Co-PI (Ongoing); Medtronic: Study Chair (Ongoing)

    Sigrid E. Sandner, MD